MedTrace Logo

Impact of Risser Stage on Pressure of Correction in Pectus Carinatum

NCT03548922 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-07-03

No results posted yet for this study

Summary

Pectus carinatum (PC) is a deformity of the anterior chest wall which is a common pediatric condition, characterized by an idiopathic overgrowth of the costal cartilages resulting in protrusion of the sternum. Knowing factors influencing pressure of correction may lead successful treatment outcomes. In a study by Lee and colleagues investigating the effectiveness of the orthosis, it was found that patients with advanced Tanner stage of pubertal development had a longer time for correction of deformity. Martinez-Ferro et al proposed that pectus carinatum may return mildly, in approximately 10% of cured patients, particularly if they have been treated before pubertal growth spurts or in case they have cured very rapidly. To the best of our knowledge factors influencing pressure of correction and treatment outcomes after compressive bracing have not been investigated before. Our aim is to investigate impact of Risser stage on pressure of correction in PC.

Conditions

  • Pectus Carinatum

Interventions

OTHER

Tanner stage

a scale of pubertal development in children, adolescents

OTHER

Risser stage

a measure showing the growth left in the spine

OTHER

Pressure of correction

an indirect parameter of the chest wall's flexibility. It is defined as the pressure applied to the patient, in the most protruding area of the chest, needed to accomplish a proper shape of the thorax.

OTHER

Pectus carinatum protrusion

distance from the point of maximum protrusion to the estimated normal level of chest wall

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Mustafa Yuksel, Prof · Marmara University

  • Gulseren Akyuz, Prof · Marmara University

  • Esra Giray, MD · Marmara University

Eligibility

Min Age
5 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-12-01
Completion
2019-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03548922 on ClinicalTrials.gov